Findeisen Sebastian, Schwilk Melanie, Haubruck Patrick, Ferbert Thomas, Helbig Lars, Miska Matthias, Schmidmaier Gerhard, Tanner Michael Christopher
University Hospital Heidelberg, Clinic for Trauma- and Reconstructive Surgery, Center for Orthopaedics, Trauma Surgery and Paraplegiology, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany.
J Clin Med. 2023 Jun 23;12(13):4239. doi: 10.3390/jcm12134239.
The treatment of large-sized bone defects remains a major challenge in trauma and orthopaedic surgery. Although there are many treatment options, there is still no clear guidance on surgical management, and the influence of defect size on radiological and clinical outcome remains unclear due to the small number of affected patients. The aim of the present study was to determine the influence of defect size on the outcome of atrophic and infected nonunions of the tibia or the femur based on the diamond concept in order to provide recommendations for treatment guidance.
All medical records, surgical reports, laboratory data and radiological images of patients treated surgically for atrophic or infected nonunions of the lower limbs (femur or tibia) between 1 January 2010 and 31 December 2020 were examined. Patients with proximal, diaphyseal or distal nonunions of the femur or tibia who were surgically treated at our institution according to the "diamond concept" and attended our standardised follow-up program were included in a database. Surgical treatment was performed as a one- or two-step procedure, depending on the type of nonunion. Patients with a segmental bone defect ≥5 cm were matched with patients suffering a bone defect <5 cm based on five established criteria. According to our inclusion and exclusion criteria, 70 patients with a bone defect ≥5 cm were suitable for analysis. Two groups were formed by matching: the study group (bone defect ≥5 cm; n = 39) and control group (bone defect <5 cm; n = 39). The study was approved by the local ethics committee (S-262/2017).
The mean defect size was 7.13 cm in the study and 2.09 cm in the control group. The chi-square test showed equal consolidation rates between the groups (SG: 53.8%; CG: 66.7%). However, the Kaplan-Meier curve and log-rank test showed a significant difference regarding the mean duration until consolidation was achieved, with an average of 15.95 months in the study and 9.24 months in the control group (α = 0.05, = 0.001). Linear regression showed a significant increase in consolidation duration with increasing defect size (R = 0.121, = 0.021). Logistic regression modelling showed a significant negative correlation between consolidation rate and revision performance, as well as an increasing number of revisions, prior surgeries and total number of surgeries performed on the limb. Clinical outcomes showed equal full weight bearing of the lower extremity after 5.54 months in the study vs. 4.86 months in the control group ( = 0.267).
Surprisingly, defect size does not seem to have a significant effect on the consolidation rate and should not be seen as a risk factor. However, for the treatment of large-sized nonunions, the follow-up period should be prolonged up to 24 months, due to the extended time until consolidation will be achieved. This period should also pass before a premature revision with new bone augmentation is performed. In addition, it should be kept in mind that as the number of previous surgeries and revisions increases, the prospects for consolidation decrease and a change in therapeutic approach may be required.
大型骨缺损的治疗仍是创伤和骨科手术中的一项重大挑战。尽管有多种治疗选择,但手术管理仍缺乏明确的指导,且由于受影响患者数量较少,缺损大小对影像学和临床结果的影响仍不明确。本研究的目的是基于菱形概念确定缺损大小对胫骨或股骨萎缩性和感染性骨不连治疗结果的影响,以便为治疗指导提供建议。
检查了2010年1月1日至2020年12月31日期间因下肢(股骨或胫骨)萎缩性或感染性骨不连接受手术治疗的患者的所有病历、手术报告、实验室数据和影像学图像。在我们机构根据“菱形概念”进行手术治疗并参加标准化随访计划的股骨或胫骨近端、骨干或远端骨不连患者被纳入数据库。根据骨不连的类型,手术治疗分为一步或两步进行。将节段性骨缺损≥5 cm的患者与骨缺损<5 cm的患者根据五个既定标准进行匹配。根据我们的纳入和排除标准,70例骨缺损≥5 cm的患者适合进行分析。通过匹配形成两组:研究组(骨缺损≥5 cm;n = 39)和对照组(骨缺损<5 cm;n = 39)。本研究经当地伦理委员会批准(S-262/2017)。
研究组的平均缺损大小为7.13 cm,对照组为2.09 cm。卡方检验显示两组之间的愈合率相等(研究组:53.8%;对照组:66.7%)。然而,Kaplan-Meier曲线和对数秩检验显示,在达到愈合的平均持续时间方面存在显著差异,研究组平均为15.95个月,对照组为9.24个月(α = 0.05, = 0.001)。线性回归显示,随着缺损大小的增加,愈合持续时间显著增加(R = 0.121, = 0.021)。逻辑回归模型显示,愈合率与翻修表现之间存在显著负相关,以及肢体上先前手术、翻修次数和手术总数的增加。临床结果显示,研究组在5.54个月后下肢完全负重,对照组在4.86个月后完全负重( = 0.267)。
令人惊讶的是,缺损大小似乎对愈合率没有显著影响,不应被视为危险因素。然而,对于大型骨不连的治疗,由于达到愈合所需的时间延长,随访期应延长至24个月。在进行新的骨增量过早翻修之前,也应经过这个时期。此外,应记住,随着先前手术和翻修次数的增加,愈合的前景降低,可能需要改变治疗方法。